Drreddys Laboratories | RDY - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Aurora Cannabis CAD 46.98M 66.36M 2025-09
Bayer EUR -1.16B 735M 2025-09
Canopy Growth CAD -1.42M 39.82M 2025-09
Cipla INR 11.69B 6.85B 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Drreddys Laboratories INR 15.43B 1.96B 2025-12
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Novartis USD 4.2B 335M 2025-09
Pacira USD 9.52M 11.45M 2025-09
Phibro Animal Health USD 4.84M 4.78M 2024-12
Prestige Brands USD 69.13M 7.35M 2025-09
Richter Gedeon HUF 78.56B 32.66B 2024-12
Sun Pharmaceuticals INR 41.68B 9.95B 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
Teva Pharmaceutical Industries USD 91M 555M 2025-12